IQVIA Holdings Inc. (IQV)
USD 146.15
(2.05%)
USD 146.15
(2.05%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 14.98 Billion USD | 4.13% |
| 2022 | 14.41 Billion USD | 3.86% |
| 2021 | 13.87 Billion USD | 22.14% |
| 2020 | 11.35 Billion USD | 2.44% |
| 2019 | 11.08 Billion USD | 6.49% |
| 2018 | 10.41 Billion USD | 6.91% |
| 2017 | 9.73 Billion USD | 41.6% |
| 2016 | 6.87 Billion USD | 19.88% |
| 2015 | 5.73 Billion USD | 5.08% |
| 2014 | 5.45 Billion USD | 7.07% |
| 2013 | 5.09 Billion USD | 4.81% |
| 2012 | 4.86 Billion USD | 12.43% |
| 2011 | 4.32 Billion USD | 10.29% |
| 2010 | 3.92 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 3.74 Billion USD | -4.32% |
| 2024 Q2 | 3.81 Billion USD | 1.98% |
| 2024 Q3 | 3.89 Billion USD | 2.15% |
| 2023 Q4 | 3.9 Billion USD | 4.63% |
| 2023 Q3 | 3.73 Billion USD | 0.21% |
| 2023 FY | 15 Billion USD | 4.13% |
| 2023 Q1 | 3.65 Billion USD | -2.33% |
| 2023 Q2 | 3.72 Billion USD | 2.08% |
| 2022 Q4 | 3.73 Billion USD | 4.97% |
| 2022 Q3 | 3.56 Billion USD | 0.59% |
| 2022 Q2 | 3.54 Billion USD | -0.76% |
| 2022 FY | 14.41 Billion USD | 3.86% |
| 2022 Q1 | 3.56 Billion USD | -1.87% |
| 2021 Q1 | 3.4 Billion USD | 3.37% |
| 2021 Q2 | 3.43 Billion USD | 0.85% |
| 2021 Q3 | 3.39 Billion USD | -1.37% |
| 2021 Q4 | 3.63 Billion USD | 7.23% |
| 2021 FY | 13.87 Billion USD | 22.14% |
| 2020 Q4 | 3.29 Billion USD | 18.38% |
| 2020 Q3 | 2.78 Billion USD | 10.51% |
| 2020 Q2 | 2.52 Billion USD | -8.46% |
| 2020 Q1 | 2.75 Billion USD | -4.87% |
| 2020 FY | 11.35 Billion USD | 2.44% |
| 2019 Q2 | 2.74 Billion USD | 2.09% |
| 2019 FY | 11.08 Billion USD | 6.49% |
| 2019 Q4 | 2.89 Billion USD | 4.55% |
| 2019 Q3 | 2.76 Billion USD | 1.06% |
| 2019 Q1 | 2.68 Billion USD | -0.15% |
| 2018 Q4 | 2.68 Billion USD | 3.62% |
| 2018 Q2 | 2.56 Billion USD | 0.16% |
| 2018 FY | 10.41 Billion USD | 6.91% |
| 2018 Q1 | 2.56 Billion USD | -0.54% |
| 2018 Q3 | 2.59 Billion USD | 1.05% |
| 2017 Q2 | 2.37 Billion USD | 2.28% |
| 2017 Q4 | 2.57 Billion USD | 4.54% |
| 2017 Q1 | 2.32 Billion USD | -0.68% |
| 2017 Q3 | 2.46 Billion USD | 3.79% |
| 2017 FY | 9.73 Billion USD | 41.6% |
| 2016 FY | 6.87 Billion USD | 19.88% |
| 2016 Q3 | 1.49 Billion USD | -3.57% |
| 2016 Q2 | 1.55 Billion USD | 4.2% |
| 2016 Q1 | 1.49 Billion USD | -2.08% |
| 2016 Q4 | 2.33 Billion USD | 56.16% |
| 2015 Q1 | 1.34 Billion USD | -4.5% |
| 2015 Q4 | 1.52 Billion USD | 6.81% |
| 2015 Q3 | 1.42 Billion USD | -1.3% |
| 2015 Q2 | 1.44 Billion USD | 7.12% |
| 2015 FY | 5.73 Billion USD | 5.08% |
| 2014 Q3 | 1.4 Billion USD | 4.4% |
| 2014 Q2 | 1.34 Billion USD | 2.54% |
| 2014 Q1 | 1.3 Billion USD | -5.17% |
| 2014 FY | 5.45 Billion USD | 7.07% |
| 2014 Q4 | 1.41 Billion USD | 0.79% |
| 2013 Q4 | 1.37 Billion USD | 15.33% |
| 2013 Q1 | 1.22 Billion USD | -3.89% |
| 2013 FY | 5.09 Billion USD | 4.81% |
| 2013 Q2 | 1.29 Billion USD | 5.44% |
| 2013 Q3 | 1.19 Billion USD | -7.71% |
| 2012 FY | 4.86 Billion USD | 12.43% |
| 2012 Q1 | 1.15 Billion USD | 0.0% |
| 2012 Q4 | 1.27 Billion USD | 6.59% |
| 2012 Q2 | 1.23 Billion USD | 6.41% |
| 2012 Q3 | 1.19 Billion USD | -2.53% |
| 2011 FY | 4.32 Billion USD | 10.29% |
| 2010 FY | 3.92 Billion USD | 0.0% |
| 2001 Q3 | 3.56 Billion USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Agilent Technologies, Inc. | 6.83 Billion USD | -119.289% |
| Charles River Laboratories International, Inc. | 4.12 Billion USD | -262.861% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | -61.954% |
| Danaher Corporation | 23.89 Billion USD | 37.279% |
| Enzo Biochem, Inc. | 31.9 Million USD | -46861.482% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | -23.207% |
| Mettler-Toledo International Inc. | 3.78 Billion USD | -295.533% |
| Qiagen N.V. | 1.96 Billion USD | -662.424% |
| Revvity, Inc. | 2.75 Billion USD | -444.76% |
| Thermo Fisher Scientific Inc. | 42.85 Billion USD | 65.037% |
| Waters Corporation | 2.95 Billion USD | -406.83% |